Clene Inc - Warrants (30/12/2025) logo

CLNNW

Other

Clene Inc - Warrants (30/12/2025)

PRE

Live · NASDAQ · May 8, Close

AI Insight

What's Moving CLNNW Today?

No stock-specific AI insight has been generated for CLNNW yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$647M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE-17.4%
Profit Margin
Debt / Equity

Trading

Volume
Avg Volume (10D)
Shares Outstanding

CLNNW News

20 articles

All 20 articles loaded

Price Data

Open
Previous Close
Day High
Day Low
52 Week High$0.04
52 Week Low$0.00

About Clene Inc - Warrants (30/12/2025)

Clene Inc., a clinical-stage biopharmaceutical company, focuses on the development of various therapies for neurodegenerative diseases. The company is headquartered in Salt Lake City, Utah.

Listed December 31, 2020

Company Details

Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot
SIC
CIK
Composite FIGI
Share Class FIGI